Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice

Glia. 2009 Aug 1;57(10):1115-29. doi: 10.1002/glia.20835.

Abstract

The primary sources of cortical gliogenesis, either during development or after adult brain injury, remain uncertain. We previously generated Nestin-CreER mice to fate-map the progeny of radial glial cells (RG), a source of astrocytes and oligodendrocytes in the nervous system. Here, we show that Nestin-CreER mice label another population of glial progenitors, namely the perinatal subventricular zone (SVZ) glioblasts, if they are crossed with stop-floxed EGFP mice and receive tamoxifen in late embryogenesis (E16-E18). Quantification showed E18 tamoxifen-induction labeled more perinatal SVZ glioblasts than RG and transitional RG combined in the newborn brain (54% vs. 22%). Time-lapse microscopy showed SVZ-glioblasts underwent complex metamorphosis and often-reciprocal transformation into transitional RG. Surprisingly, the E10-dosed RG progenitors produced astrocytes, but no oligodendrocytes, whereas E18-induction fate-mapped both astrocytes and NG2+ oligodendrocyte precursors in the postnatal brain. These results suggest that cortical oligodendrocytes mostly derive from perinatal SVZ glioblast progenitors. Further, by combining genetic fate-mapping and BrdU-labeling, we showed that cortical astrocytes cease proliferation soon after birth (<P10) and only undergo nonproliferative gliosis (i.e., increased GFAP expression without cell-division) after stab-wound injury in adult brains. By contrast, 9.7% of cortical NG2+ progenitors remained mitotic at P29, and the ratio rose to 13.8% after stab-wound injury. Together, these results suggest NG2+ progenitors, rather than GFAP+ astrocytes, are the primary source of proliferative gliosis after adult brain injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / analysis
  • Antigens / metabolism
  • Astrocytes / cytology
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • Brain Injuries / metabolism*
  • Brain Injuries / pathology
  • Brain Injuries / physiopathology
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics*
  • Cell Lineage / drug effects
  • Cell Lineage / genetics*
  • Cell Proliferation / drug effects
  • Cerebral Cortex / injuries
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / physiopathology
  • Chromosome Mapping / methods*
  • Disease Models, Animal
  • Glial Fibrillary Acidic Protein / analysis
  • Glial Fibrillary Acidic Protein / metabolism
  • Gliosis / metabolism*
  • Gliosis / pathology
  • Gliosis / physiopathology
  • Green Fluorescent Proteins / genetics
  • Intermediate Filament Proteins / analysis
  • Intermediate Filament Proteins / metabolism*
  • Mice
  • Mice, Transgenic
  • Nerve Tissue Proteins / analysis
  • Nerve Tissue Proteins / metabolism*
  • Nestin
  • Neuroglia / cytology
  • Neuroglia / drug effects
  • Neuroglia / metabolism*
  • Oligodendroglia / cytology
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism
  • Organ Culture Techniques
  • Proteoglycans / analysis
  • Proteoglycans / metabolism
  • Selective Estrogen Receptor Modulators / pharmacology
  • Stem Cells / cytology
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Tamoxifen / pharmacology

Substances

  • Antigens
  • Glial Fibrillary Acidic Protein
  • Intermediate Filament Proteins
  • Nerve Tissue Proteins
  • Nes protein, mouse
  • Nestin
  • Proteoglycans
  • Selective Estrogen Receptor Modulators
  • chondroitin sulfate proteoglycan 4
  • enhanced green fluorescent protein
  • Tamoxifen
  • Green Fluorescent Proteins